Constant image quality and excellent dose efficiency: OPTIQ and Structure Scout in clinical use

439
This advertorial is sponsored by Siemens Healthineers.
Highlights:
  • Philippe Pereira (SLK-Clinics GmbH, Heilbronn, Germany) pairing OPTIQ with personalised, multidisciplinary oncological medicine, “we have a big and bright future”.
  • Bernhard Gebauer (Charité University Hospital, Berlin, Germany) expands on the “excellent effect” of the new ARTIS icono technology when performing prostate artery embolization (PAE) and uterine artery embolization (UAE).
  • Maximilian de Bucourt (Charité University Hospital, Berlin, Germany), dives into
    why OPTIQ radiation exposure control provides “huge step forward” in CO2 angiography.
  • Bernhard Meyer (Hanover Medical School, Hannover, Germany) shares
    his team’s “amazing” experience after transitioning to Structure Scout and expands on its “essential benefits” during material-specific imaging.
  • Thomas Werncke (Hanover Medical School, Hanover, Germany) speaks to about his research into imaging quality, radiation dose reduction and material-specific imaging variables when using Siemens Heathineers’ OPTIQ and Structure Scout technology.

LEAVE A REPLY

Please enter your comment!
Please enter your name here